Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intranasal ketamine versus ketorolac for acute non-traumatic headache
IRCT20180108038276N3Phase 3Completed
- Sponsor
- Kermanshah University of Medical Sciences
- Start
- May 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of ketamine, ketorolac and Normal Saline-Benha University in Headache (2 arms), sponsored by Kermanshah University of Medical Sciences. Primary endpoint: Pain score based on visual analog score. Started May 2019; status: completed.
02
Drugs
ketamineketorolacNormal Saline-Benha University
03
Conditions
Headache
Beyond the preview
Go deeper on IRCT20180108038276N3.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20180108038276N3.